Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

A20 protein is crucial for normal skin and hair development.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Topical tofacitinib is effective and safe for treating alopecia areata.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

BRG1 is essential for skin cells to move and heal wounds properly.

Blocking the Wnt/β‐catenin pathway can speed up wound healing, reduce scarring, and improve cartilage repair.

Certain cancer drugs can cause skin issues like rashes and itching.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.